|
FOR IMMEDIATE RELEASE
|
DRG International, Inc., Beijing Representative Office attended ChinaMed ‘12 exhibition held March 23 – 25 in Beijing |
|
The DRG Beijing Office in China manned the booth at the 24th International Medical Instruments and Equipment Exhibition (CHINA MED 2012). DRG presented the many visitors with the new array of DRG kits developed over the last year, Active Renin and Aldosterone, but also Tumor Markers such as CA 72-4 and CA 19-9. There was strong interest in the OB/GYN kits such as HPL, 17-OH Progesterone, and Estrone. The customers of DRG mentioned that they are very satisfied with the performance, dependability, and quality of DRG kits. The Chinese visitors, however, were particularly interested in whether the DRG kits have been registered with the SFDA (the Chinese FDA) for Clinical sales. Several kits have already been registered and many more are in the process of being registered right now. While the vast majority of visitors to the Show were from China, some came from Mongolia, as well as many visitors from India.
DRG’s booth in ChinaMed ‘12
DRG’s distributor, Mr. Namkhainorov Lkhagvasuren (center) and interpreter |
